OPK – opko health, inc. (US:NASDAQ)
Stock Stats
News
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
OPKO Health's ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck [Yahoo! Finance]
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
OPKO Health, Inc. (NASDAQ: OPK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Form 4 OPKO HEALTH, INC. For: Dec 13 Filed by: FROST PHILLIP MD ET AL
Form 4 OPKO HEALTH, INC. For: Dec 11 Filed by: FROST PHILLIP MD ET AL
Form 4 OPKO HEALTH, INC. For: Nov 29 Filed by: FROST PHILLIP MD ET AL
Form 4 OPKO HEALTH, INC. For: Nov 22 Filed by: FROST PHILLIP MD ET AL
Form 4/A OPKO HEALTH, INC. For: Nov 08 Filed by: FROST PHILLIP MD ET AL
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.